SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-22-008098
Filing Date
2022-05-10
Accepted
2022-05-10 16:09:59
Documents
65
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q azyo-20220331x10q.htm   iXBRL 10-Q 1199453
2 EX-31.1 azyo-20220331xex31d1.htm EX-31.1 14650
3 EX-31.2 azyo-20220331xex31d2.htm EX-31.2 14648
4 EX-32.1 azyo-20220331xex32d1.htm EX-32.1 6759
5 EX-32.2 azyo-20220331xex32d2.htm EX-32.2 6719
  Complete submission text file 0001558370-22-008098.txt   5479704

Data Files

Seq Description Document Type Size
6 EX-101.SCH azyo-20220331.xsd EX-101.SCH 41130
7 EX-101.CAL azyo-20220331_cal.xml EX-101.CAL 37442
8 EX-101.DEF azyo-20220331_def.xml EX-101.DEF 202490
9 EX-101.LAB azyo-20220331_lab.xml EX-101.LAB 403988
10 EX-101.PRE azyo-20220331_pre.xml EX-101.PRE 308080
59 EXTRACTED XBRL INSTANCE DOCUMENT azyo-20220331x10q_htm.xml XML 802810
Mailing Address 12510 PROSPERITY DRIVE SUITE 370 SILVER SPRING MD 20904
Business Address 12510 PROSPERITY DRIVE SUITE 370 SILVER SPRING MD 20904 240-247-1143
AZIYO BIOLOGICS, INC. (Filer) CIK: 0001708527 (see all company filings)

IRS No.: 474790334 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39577 | Film No.: 22909669
SIC: 2836 Biological Products, (No Diagnostic Substances)